Head-to-head data, presented at OPTIONS XII for the Control of Influenza Conference, demonstrates advantage of sa-mRNA over conventional mRNA in duration of ...

Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...

South Korea's Gwangju FC hung on to hand J-League side Kawasaki Frontale a 1-0 defeat on Tuesday to secure back-to-back Asian Champions League Elite wins as ...

CSL Seqirus, a business of CSL (ASX: CSL), today announced data from a range of real-world evidence (RWE) studies, highlighting the important role influenza vaccination plays in protecting public ...

Patients had fewer bleeds after treatment with Beqvez compared to standard treatment, but questions remain about which ...

At CSL Group, Glenn will lead the company's technology strategy and development, focusing on enhancing its portfolio of multi ...

The biotech last traded there on September 9. The post Can the CSL share price push back above $300? appeared first on The ...

A day after the football team scored a win at the football field, Pella’s volleyball team was in action the next day at the ...

Carolina Panthers' Shaq Thompson is out for the season with a torn Achilles, impacting the team's defense and leadership.

Ian Rapoport of NFL Network first reported the news and said he's having an MRI on Monday to confirm the injury.

Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...

CSL Ltd. (CMXHF.PK) and Arcturus Therapeutics Holdings Inc. (ARCT), Monday announced that self-amplifying or sa-mRNA COVID-19 vaccine ...